Healthcare
Biogen Inc. (BIIB)
Biogen Inc. stock analysis and opportunity scoring
$218.50
↓ -1.35%
Biogen Inc. (BIIB) at a glance
Biogen Inc. (BIIB) is a publicly traded company in the Healthcare - Drug Manufacturers - General sector tracked by MKD Intelligence.
BIIB last traded at $202.19 as of 2026-08-29.
MKD Intelligence assigns BIIB a composite opportunity score of 66 out of 100, indicating favourable conditions across trend, momentum and volume factors.
The risk score for BIIB is 34 out of 100 (moderate), where a higher number means greater expected volatility.
Price History
High
$221.56
Low
$200.14
Period
Aug 28 - Jul 24 (26d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
No recent news available.
Upcoming Events
Data as of Aug 29
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.